Home › Notable Labs Raises $10M in Series A Financing

Notable Labs Raises $10M in Series A Financing

Sep 06, 2017

NEW YORK (360Dx) – San Francisco-based Notable Labs today announced that it has raised $10 million in Series A funding, which it will put toward building its technology platform and team, as well as clinical feasibility studies related to blood cancers.

The firm provides a drug-testing service for oncologists identifying treatment options for blood-cancer patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Sep
27
Featured Webinar

Large-scale, Prospective Tumor and Normal Sequence to Accelerate Biomarker Discovery and Guide Clinical Care

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Oct
12
Featured Webinar

Precision Oncology Roundtable: Ask the Experts about NGS-based Tumor Profiling

Sponsored by
PierianDx

This webinar will be a roundtable discussion on the adoption of a commercial gene panel for tumor profiling at several leading US cancer centers. 

Oct
17
Featured Webinar

Profiling the Tumor Immune Microenvironment During Neoadjuvant Therapy for Soft-Tissue Sarcomas

This webinar will discuss the benefits of genomically profiling the immune microenvironment of soft tissue sarcomas during neoadjuvant therapy.

What's Popular?

In Cancer

  1. UK Foundation Outlines Recommendations for Effective ctDNA Testing in Lung Cancer

  2. FDA Approves Merck's Keytruda, Agilent Dako CDx for Gastric Cancer Indications

  3. Exosome Diagnostics Launches Evidence Development Study for Prostate Cancer Test

  4. FDA Approves Agilent Complementary Dx for Two Additional Indications

  5. DxTerity, City of Hope Partner to Develop Blood Test for Radiation Therapy Response

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.